Vasodilator effects of adrenomedullin on retinal arterioles in streptozotocin-induced diabetic rats

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 5, 2006, Pages 317-322

  Kaneko, Yoshiko ^a   Saito, Maki ^a   Mori, Asami ^a   Sakamoto, Kenji ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENOMEDULLIN; GLUCOSE; NORADRENALIN; STREPTOZOCIN; TETRODOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DEPRESSOR RESPONSE; DOSE RESPONSE; IN VIVO STUDY; MALE; NERVE CONDUCTION; NONHUMAN; OPHTHALMOSCOPY; RAT; REGULATORY MECHANISM; RETINA ARTERY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; STREPTOZOCIN DIABETES; SYSTEMIC CIRCULATION; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; HEART RATE; MALE; RATS; RATS, WISTAR; RETINAL ARTERY; STREPTOZOCIN; VASODILATOR AGENTS;

EID: 33750691412     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.317     Document Type: Article

References (26)

1. Ghirlanda, G., Di Leo, M.A., Caputo, S., et al. From functional to microvascular abnormalities in early diabetic retinopathy. Diab. Metab. Rev. 13:15-35, 1997.
2. De La Cruz, J.P., Gonzalez-Correa, J.A., Guerrero, A., et al. Pharmacological approach to diabetic retinopathy. Diab. Metab. Res. Rev. 20:91-113, 2004.
3. Feke, G.T., Buzney, S.M., Ogasawara, H., et al. Retinal circulatory abnormalities in Type 1 diabetes. Invest. Ophthalmol. Vis. Sci. 35:2968-2975, 1994.
4. Antonetti, D.A., Lieth, E., Barber, A.J., et al. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin. Ophthalmol. 14:240-248, 1999.
5. Kitamura, K., Kangawa, K., Kawamoto, M., et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553-560, 1993.
6. Nikitenko, L.L., Smith, D.M., Hague, S., et al. Adrenomedullin and the microvasculature. Trends Pharmacol. Sci. 23:101-103, 2002.
7. Okamura, T., Ayajiki, K., Kangawa, K., et al. Mechanism of adrenomedullin-induced relaxation in isolated canine retinal arteries. Invest. Ophthalmol. Vis. Sci. 38:56-61, 1997.
8. Boussery, K., Delaey, C., and Van de Voorde, J. Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 45:552-559, 2004.
9. Dorner, G.T., Garhofer, G., Huemer, K.H., et al. Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 44:3947-3951, 2003.
10. Clementi, G., Floriddia, M.L., Prato, A., et al. Adrenomedullin and ocular inflammation in the rabbit. Eur. J. Pharmacol. 400:321-326, 2000.
11. Hayashi, M., Shimosawa, T., Isaka, M., et al. Plasma adrenomedullin in diabetes. Lancet 350:1449-1450, 1997.
12. Udono, T., Takahashi, K., Takano, S., et al. Elevated adrenomedullin in the vitreous of patients with proliferative vitreoretinopathy. Am. J. Ophthalmol. 128:765-767, 1999.
13. Ito, S., Fujisawa, K., Sakamoto, T., et al. Elevated adrenomedullin in the vitreous of patients with diabetic retinopathy. Ophthalmologica 217:53-57, 2003.
14. G-nitro-L-arginine-treated rats. J. Cardiovasc. Pharmacol. 35:630-637, 2000.
15. Arnold, J.V., Gates, J.W., and Taylor, K.M. Possible errors in the measurement of retinal lesions. Invest. Ophthalmol. Vis. Sci. 34:2576-2580, 1993.
16. Sugo, S., Minamino, N., Kangawa, K., et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem. Biophys. Res. Commun. 201:1160-1166, 1994.
17. Ishizaka, Y., Ishizakam, Y., Tanakam, M., et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 200:642-646, 1994.
18. Hirata, Y., Hayakawa, H., Suzuki, Y., et al. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 25:790-795, 1995.
19. Hayakawa, H., Hirata, Y., Kakoki, M., et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension 33:689-693, 1999.
20. + channels. Am. J. Physiol. Heart Circ. Physiol. 279:H2620-H2626, 2000.
21. Oyama, Y., Kawasaki, H., Hattori, Y., et al. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 132:75-78, 1986.
22. De Vriese, A.S., Verbeuren, T.J., Van de Voorde, J., et al. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130:963-974, 2000.
23. Yu, P.K., Yu, D.Y., Cringle, S.J., et al. Tetrahydrobiopterin reverses the impairment of acetylcholine-induced vasodilatation in diabetic ocular microvasculature. J. Ocul. Pharmacol. Ther. 17:123-129, 2001.
24. Horio, N., Clermont, A.C., Abiko, A., et al. Angiotensin AT1 receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats. Diabetologia 47:113-123, 2004.
25. Abiru, T., Kamata, K., and Kasuya, Y. Attenuation of depressor response induced by platelet activating factor and acetylcholine in streptozotocin- induced diabetic rats. J. Pharmacobiodyn. 4:293-300, 1991.
26. Nishimatsu, H., Suzuki, E., Satonaka, H., et al. Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. 288:H1770-H1776, 2005.